Investors who Lost Money on Viatris Inc. (VTRS) Should Contact Levi & Korsinsky About Pending Class Action - VTRS
NEW YORK, NY / ACCESS Newswire / April 13, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws...
VTRS Investors Have the Opportunity to Lead the Viatris Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Viatris To Contact Him Directly To Discuss Their Options
VTRS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Viatris Inc. Investors with Losses Have Opportunity to Lead Class Action L...
NEW YORK CITY, NY / ACCESS Newswire / April 13, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Vi...
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
NEW YORK CITY, NY / ACCESS Newswire / April 12, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities o...
Lost Money on Viatris Inc. (VTRS)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky
NEW YORK CITY, NY / ACCESS Newswire / April 12, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities...
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Viatris Inc. of Class Action Lawsuit and Upcoming Deadlines...
NEW YORK, April 12, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Viatris, Inc. (“Viatris” or the “Company”) (NASDAQ: VTRS). Such investors a...
What's in the Cards for Viatris Stock This Q4 Earnings?
VTRS' Q4 results are likely to gain from new product launches in all major geographies.
Viatris Inc. (VTRS) 43rd Annual J.P. Morgan Healthcare Conference 2025 (Transcript)
Viatris Inc. (NASDAQ:VTRS ) 43rd Annual J.P. Morgan Healthcare Conference 2025 January 14, 2025 11:15 AM ET Company Participants Scott Smith - CEO Doretta Mistras - CFO Philippe Martin - Chief R&D ...
Viatris: Looking At High Free Cash Flow Yield As Business Stabilizes
We have rated Viatris in the "neutral/hold" category since 2021. Over this time, the stock has lagged Treasury bills, despite sporting a high double digit "free cash flow yield". We tell you why th...
UK watchdog fines Viatris $1.9 mln over rule breach in Theramex probe
Britain's competition watchdog fined U.S. firm Viatris 1.5 million pounds ($1.88 million) on Friday for violating an order during its investigation into Theramex's acquisition of European rights to...
Viatris Inc. (VTRS) UBS Global Healthcare Conference (Transcript)
Viatris Inc. (NASDAQ:VTRS ) UBS Global Healthcare Conference November 12, 2024 11:45 AM ET Company Participants Doretta Mistras - CFO Conference Call Participants Ashwani Verma - UBS Ashwani Verma ...
Bargain Priced Viatris Reports Strong Q3 Earnings Results
Bargain Priced Viatris Reports Strong Q3 Earnings Results
Viatris Beats on Q3 Earnings and Revenues, Lowers Profit Guidance
VTRS Q3 earnings and sales beat estimates. New products perform well.
Viatris Inc. (VTRS) Q3 2024 Earnings Call Transcript
Viatris Inc. (NASDAQ:VTRS ) Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ET Company Participants Bill Szablewski - Head of Capital Markets Scott Smith - CEO Philippe Martin - Chief R&D...
Lexicon Announces Exclusive Licensing Agreement With Viatris for Sotagliflozin in All Markets Outside of the U.S. and Europe
-Lexicon to receive an upfront payment of $25 million and the potential for contingent regulatory and commercial milestone payments -Lexicon to receive an upfront payment of $25 million and the pot...
Related Companies